Scientists probe lung 'Memory' cells to unlock asthma mysteries
NCT ID NCT03455959
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study looks at how certain immune cells, called memory Th2 cells, that stay in the lungs may trigger allergic asthma attacks when a person breathes in allergens like cat or dust mite dander. Researchers will take samples from the airways of 37 people with mild to moderate allergic asthma and compare them to healthy volunteers. The goal is to understand these cells better, which could lead to new ways to prevent asthma attacks in the future.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this could point toward new treatments that target memory Th2 cells to prevent asthma flare-ups.
- What could go wrong
- This is a small, early-stage observational study, not testing a treatment. Results may not lead to therapies or apply to all asthma patients.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ASTHMA, ALLERGIC are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Massachusetts General Hospital
Boston, Massachusetts, 02116, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.